-
admin
Posts
Toll Brothers Opens Newest Collection of Luxury Homes in Griffith Lakes Community in Charlotte, North Carolina
CHARLOTTE, N.C., July 02, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the opening of its newest...
Increasing Adoption of Non-Invasive Aesthetic Procedures & Wellness Services Propels the Growth of the Global Medical Spa Market; says TNR, The Niche Research
Global Medical Spa Market is Expected to Reach US$ 86.6 Bn by 2034; Growing at a CAGR of 14.6% over the Forecast Period (2024 –...
La Dolce Vita Emphasizes Water Safety Near Crab Island
DESTIN, Fla., July 02, 2024 (GLOBE NEWSWIRE) — As summer heats up and more people flock to the waters of Crab Island, La Dolce Vita...
Cosmetic Chemicals Market Size Expected to Reach USD 49.48 Billion by 2033
The global cosmetic chemicals market size was USD 24.91 billion in 2023, calculated at USD 26.81 billion in 2024, and is expected to reach around...
Marine Functional Ingredients Market at a CAGR of 8.6% during the forecast period (2024-2030) – Exactitude Consultancy
North accounted for the largest market in the Marine Functional Ingredients market. North america accounted for the 40 % market share across the globe Luton,...
BetterLife Announces Closing of a Private Placement
VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging...
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA) (“SPAC”) announce signing...
Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors
Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of...
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, July 02, 2024 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release...